Response Genetics, Inc
RGDXQ · OTC
3/31/2015 | 12/31/2014 | 9/30/2014 | 6/30/2014 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | 0.11 | -0.08 | 0.58 |
| FCF Yield | -11.03% | -30.43% | -15.99% | -9.19% |
| EV / EBITDA | -7.62 | -6.90 | -9.60 | -12.19 |
| Quality | ||||
| ROIC | -60.62% | -33.57% | -28.75% | -46.31% |
| Gross Margin | 38.94% | 40.07% | 43.05% | 39.60% |
| Cash Conversion Ratio | 0.47 | 1.09 | 1.18 | 1.01 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.58% | -3.72% | -1.34% | -1.50% |
| Free Cash Flow Growth | 49.62% | 11.91% | -29.54% | -4.31% |
| Safety | ||||
| Net Debt / EBITDA | -2.67 | -2.60 | -1.17 | 0.15 |
| Interest Coverage | -9.65 | -8.56 | -12.95 | -134.23 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 77.48 | 51.67 | 89.34 | 79.54 |